- Home
- RBKB vs TNYA Comparison
RBKB vs TNYA Comparison
Compare RBKB & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RBKB | TNYA |
|---|---|---|
| Founded | 1860 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.4M | 157.9M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RBKB | TNYA |
|---|---|---|
| Price | $11.93 | $0.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.25 |
| AVG Volume (30 Days) | 6.9K | ★ 4.0M |
| Earning Date | 01-29-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | ★ $51,705,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.93 | ★ N/A |
| Revenue Growth | ★ 99.55 | N/A |
| 52 Week Low | $9.31 | $0.36 |
| 52 Week High | $13.99 | $2.35 |
Technical Indicators
Market Signals| Indicator | RBKB | TNYA |
|---|---|---|
| Relative Strength Index (RSI) | 47.05 | 59.66 |
| Support Level | $11.70 | $0.65 |
| Resistance Level | $12.50 | $0.79 |
| Average True Range (ATR) | 0.34 | 0.06 |
| MACD | -0.05 | 0.04 |
| Stochastic Oscillator | 44.44 | 91.59 |
Price Performance
Historical ComparisonAbout RBKB Rhinebeck Bancorp Inc.
Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one-to four-family residential real estate loans, and to purchase investment securities.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.